NCT07148193Recruiting
Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)
Understanding Long-Term Sarcoma Survivorship: Risk Profiles, Outcomes and Unmet Needs - A Joint Project of Research, Sarcoma Centres and Patient Experts (PROSa+)
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
The study PROSa+ aims to assess patient-reported outcomes (PROs), patient-reported experiences (PREs), and the socioeconomic situation of long-term sarcoma survivors (≥ 5 years post-diagnosis, with or without active disease) in Germany. The mixed-methods research design includes a multicenter observational study with a cross-sectional questionnaire survey involving 1,600 participants (paper, online), qualitative interviews with up to 60 participants, and longitudinal analyses combining data from existing sarcoma registries and the previous PROSa study conducted between 2017 and 2020.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1600 (estimated)
- First submitted
- 22 Aug 2025
- Start date
- Nov 2025
- Primary completion date
- Sept 2027
- Lead sponsor
- Technische Universität Dresden
- Diseases
- Sarcoma
- NCT number
- NCT07148193
What you commit to
- Study type: Observational
- Planned participants: 1600
- From Nov 2025 to the primary completion date, Sept 2027
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Inability to complete a structured questionnaire (e.g., due to insufficient German language skills, cognitive impairment, dementia)
Other
- Diagnosis of Desmoid tumors
Who the study is looking for
- Diagnosis of sarcoma according to the International Classification of Diseases for Oncology (ICD-O) and World Health Organization (WHO) classification, including soft tissue sarcoma, bone sarcoma, and GIST
- At least 5 years since initial sarcoma diagnosis
- With or without active disease
- Age ≥18 years at the time of study participation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Technical University Dresden Coordinator of this site? Confirm its status | Dresden | Germany | Recruiting |
| University Hospital Essen Coordinator of this site? Confirm its status | Essen | Germany | Not yet recruiting |
| NCT Heidelberg Coordinator of this site? Confirm its status | Heidelberg | Germany | Recruiting |
| Sarcoma Center Mannheim Coordinator of this site? Confirm its status | Mannheim | Germany | Recruiting |
| Deutsche Sarkom-Stiftung Coordinator of this site? Confirm its status | Wölfersheim | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.